1. Handbook
  2. Subjects
  3. Biomedicine: Molecule to Malady

Biomedicine: Molecule to Malady (BIOM30002)

Undergraduate level 3Points: 12.5On Campus (Parkville)

You’re viewing the 2017 Handbook:
Or view archived Handbooks
You’re currently viewing the 2017 version of this subject


Year of offer2017
Subject levelUndergraduate Level 3
Subject codeBIOM30002
Semester 1
FeesSubject EFTSL, Level, Discipline & Census Date

This subject provides students with an insight into how medical problems are approached in the 21st century. Students spend 5-6 hours addressing each of six “maladies”, selected to demonstrate the holistic nature of medical practice and the integration of biomedical research into the development of novel diagnostics and evidence-based therapies.

Each module includes elements of normal anatomy and physiology, the epidemiology and the pathology of disease, including any genetic, microbiological, immunological, and inflammatory processes that underpin the pathology. Finally, the public health implications of the malady are considered wherever possible.

Intended learning outcomes

Upon completion of this unit, students should:

LO1: understand that the treatment of complex diseases requires a multidisciplinary and holistic approach;

LO2: appreciate that for many diseases, an understanding of the biological bases of the disease leads to precise diagnostic and therapeutic opportunities;

LO3: understand the molecular, cellular and physiological bases of selected diseases;

LO4: acquire a theoretical framework for the systematic study of complex diseases.

Generic skills

On completion of this subject, students should have developed the following generic skills:

  • the ability to interpret scientific literature and interpret data from electronic databases;
  • the capacity to integrate knowledge across disciplines;
  • the ability to comprehend a question, evaluate the relevant information and communicate an answer;
  • an appreciation of the ability to communicate scientific knowledge to an informed lay audience.

Last updated: 23 January 2019